JournalFeed

Anti-Plt For Failed Thromobolysis | Early DAPT?

JournalFeed

Show Notes

The JournalFeed podcast for the week of June 22-26, 2026.

These are summaries from just 2 of the 5 articles we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.

Thursday’s Spoon Feed: Tirofiban resulted in greater 90-day excellent neurological outcomes vs. placebo in patients with no medium or large vessel occlusion (LVO) who were not improving with with tenecteplase (TNK), NNT = 9.

Friday’s Spoon Feed: Dual antiplatelet therapy (DAPT) with ticagrelor plus aspirin vs. placebo in patients with stroke treated with thrombolysis resulted in better 90-day excellent neurological outcome, NNT = 15, without a significant increase in symptomatic intracranial hemorrhage (sICH).

More from JournalFeed

Oct 17, 2026

The JournalFeed podcast

Oct 10, 2026

The JournalFeed podcast

Oct 3, 2026

The JournalFeed podcast

Sep 19, 2026

The JournalFeed podcast

See all episodes →